Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia

All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) are essential for acute promyelocytic leukemia (APL) treatment. It has been reported that mutations in PML-RARA confer resistance to ATRA and ATO, and are associated with poor prognosis. Although most PML-RARA mutations were point mutations,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Hattori, Hikaru, Ishikawa, Yuichi, Kawashima, Naomi, Akashi, Akimi, Yamaguchi, Yohei, Harada, Yasuhiko, Hirano, Daiki, Adachi, Yoshiya, Miyao, Kotaro, Ushijima, Yoko, Terakura, Seitaro, Nishida, Tetsuya, Matsushita, Tadashi, Kiyoi, Hitoshi
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173414/
https://ncbi.nlm.nih.gov/pubmed/30289902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0204850
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items